Oncology Institute
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $141,957 | $136,564 | $119,802 | $104,406 |
Gross Profit | 15,821 | 18,920 | 17,501 | 17,249 |
EBITDA | 5,359 | -12,861 | -9,406 | -12,231 |
EBIT | 3,727 | -14,584 | -11,211 | -14,015 |
Net Income | -7,508 | -16,504 | -17,009 | -19,585 |
Net Change In Cash | 141,957 | 136,564 | 119,802 | 104,406 |
Free Cash Flow | 2,173 | -13,234 | -11,410 | -5,316 |
Cash | 33,565 | 27,658 | 30,292 | 39,739 |
Basic Shares | 1,014,566 | 974,747 | 932,036 | 77,099 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $502,729 | $393,412 | $324,239 | $252,483 |
Gross Profit | 69,491 | 53,997 | 59,573 | 52,093 |
EBITDA | -29,139 | -53,831 | -54,278 | -67,596 |
EBIT | -36,083 | -60,118 | -60,151 | -72,007 |
Net Income | -60,606 | -64,663 | -83,068 | 152 |
Net Change In Cash | 502,729 | 393,412 | 324,239 | 252,483 |
Cost of Revenue | -101,164 | |||
Free Cash Flow | -27,787 | -30,327 | -40,882 | -67,285 |
Cash | 33,565 | 49,669 | 33,488 | 14,010 |
Basic Shares | 923,893 | 75,043 | 73,748 | 80,605 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.15 |
